Description

Dinastat (parecoxib) powder for infusions 40 mg. vial №10

Ingredients:

Dinastat contains parecoxib as the active ingredient.

Dosage:

Each vial of Dinastat contains 40 mg of parecoxib. The dosage should be determined by a healthcare professional based on the patient’s condition.

Indications:

Dinastat is indicated for the treatment of acute postoperative pain.

Contraindications:

Do not use Dinastat if you are allergic to parecoxib or other NSAIDs.

Directions:

The powder should be reconstituted with the appropriate diluent as directed by a healthcare provider and administered by intravenous infusion.

Scientific Evidence:

Studies have shown that parecoxib, the active ingredient in Dinastat, is effective in managing postoperative pain due to its COX-2 inhibitory properties. Clinical trials have demonstrated its analgesic efficacy and safety profile in various surgical settings.

Additional Information:

It is important to monitor patients for any signs of adverse reactions while on Dinastat therapy. Consult with a healthcare professional for personalized dosing and monitoring.

Parecoxib, a prodrug of valdecoxib, exerts its pharmacological effects by inhibiting the COX-2 enzyme, thereby reducing the production of inflammatory mediators. This mechanism helps in alleviating pain and inflammation postoperatively.

Compared to traditional NSAIDs, parecoxib has shown to have a lower risk of gastrointestinal adverse effects, making it a favorable option for pain management in surgical patients.